ADA Guidelines Urge Routine Diabetes Screening for Liver Disease
New standards recommend MASLD evaluation using FIB-4 scoring and elastography to prevent serious liver complications
Topline
The American Diabetes Association (ADA) now recommends routine screening for metabolic dysfunction-associated steatotic liver disease (MASLD) among all adults with type 2 diabetes and prediabetes, emphasizing the use of noninvasive tools like FIB-4 scoring and transient elastography to detect early liver damage and initiate appropriate interventi…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.